UBS AM’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-42,000
| Closed | -$2.7M | – | 2897 |
|
|
2018
Q3 | $2.7M | Buy |
42,000
+2,894
| +7% | +$176K | ﹤0.01% | 1379 |
|
|
2018
Q2 | $1.91M | Sell |
39,106
-4,811
| -11% | -$249K | ﹤0.01% | 1526 |
|
|
2018
Q1 | $2.06M | Buy |
43,917
+7,609
| +21% | +$366K | ﹤0.01% | 1451 |
|
|
2017
Q4 | $1.81M | Sell |
36,308
-6,706
| -16% | -$333K | ﹤0.01% | 1479 |
|
|
2017
Q3 | $2.49M | Sell |
43,014
-187,764
| -81% | -$11.2M | ﹤0.01% | 1314 |
|
|
2017
Q2 | $15.5M | Sell |
230,778
-16,721
| -7% | -$1.06M | 0.02% | 801 |
|
|
2017
Q1 | $16.2M | Buy |
247,499
+215,763
| +680% | +$13.3M | 0.02% | 775 |
|
|
2016
Q4 | $1.8M | Sell |
31,736
-11,842
| -27% | -$685K | ﹤0.01% | 1329 |
|
|
2016
Q3 | $2.58M | Hold |
43,578
| – | – | ﹤0.01% | 1281 |
|
|
2016
Q2 | $2.85M | Sell |
43,578
-153
| -0.3% | -$10.4K | ﹤0.01% | 1226 |
|
|
2016
Q1 | $3.03M | Sell |
43,731
-3,677
| -8% | -$245K | ﹤0.01% | 1200 |
|
|
2015
Q4 | $3.48M | Buy |
47,408
+3,143
| +7% | +$224K | ﹤0.01% | 1197 |
|
|
2015
Q3 | $3.14M | Buy |
44,265
+11,131
| +34% | +$903K | ﹤0.01% | 1227 |
|
|
2015
Q2 | $2.88M | Buy |
33,134
+2,300
| +7% | +$174K | ﹤0.01% | 1242 |
|
|
2015
Q1 | $2.27M | Buy |
30,834
+800
| +3% | +$56.8K | ﹤0.01% | 1309 |
|
|
2014
Q4 | $2.16M | Buy |
30,034
+500
| +2% | +$34.6K | ﹤0.01% | 1292 |
|
|
2014
Q3 | $2.04M | Buy |
29,534
+500
| +2% | +$35.2K | ﹤0.01% | 1293 |
|
|
2014
Q2 | $1.8M | Hold |
29,034
| – | – | ﹤0.01% | 1365 |
|
|
2014
Q1 | $1.58M | Buy |
29,034
+3,751
| +15% | +$200K | ﹤0.01% | 1395 |
|
|
2013
Q4 | $1.34M | Buy |
25,283
+500
| +2% | +$25.1K | ﹤0.01% | 1417 |
|
|
2013
Q3 | $1.16M | Hold |
24,783
| – | – | ﹤0.01% | 1442 |
|
|
2013
Q2 | $1.21M | Buy |
+24,783
| New | +$1.19M | ﹤0.01% | 1377 |
|
Other funds holding LPNT
UBS AM's LPNT Position: Q4 2018 in Review
UBS AM sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 42,000 shares — an estimated $2.7M sold.
UBS AM first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $16.2M in Q1 2017. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- UBS AM reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- UBS AM sold 42,000 LifePoint Health, Inc. shares in Q4 2018, an estimated $2.7M.
- UBS AM first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
- UBS AM's LifePoint Health, Inc. position peaked at $16.2M in Q1 2017.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.